> 0 1 0 1 O
10 1 3 1 3 B-lower_bound
mg 4 6 4 6 I-lower_bound
prednisone 7 17 7 17 B-treatment
per 18 21 18 21 O
day 22 25 22 25 O
or 26 28 26 28 O
equivalent 29 39 29 39 O

Absolute 0 8 40 48 B-clinical_variable
neutrophil 9 19 49 59 I-clinical_variable
count 20 25 60 65 I-clinical_variable
( 26 27 66 67 I-clinical_variable
ANC)>1500 27 36 67 76 I-clinical_variable
/ 36 37 76 77 I-lower_bound
mm3 37 40 77 80 I-lower_bound

Age 0 3 81 84 B-age
18 4 6 85 87 B-lower_bound
- 6 7 87 88 O
76 7 9 88 90 B-upper_bound
years 10 15 91 96 I-upper_bound

Calculated 0 10 97 107 B-clinical_variable
creatinine 11 21 108 118 I-clinical_variable
clearance 22 31 119 128 I-clinical_variable
> 32 33 129 130 O
30ml 33 37 130 134 B-lower_bound
/ 37 38 134 135 I-lower_bound
m 38 39 135 136 I-lower_bound

Creatinine<2mg 0 14 137 151 B-clinical_variable
/ 14 15 151 152 I-upper_bound
dl 15 17 152 154 I-upper_bound

Evidence 0 8 155 163 O
of 9 11 164 166 O
clinically 12 22 167 177 O
significant 23 34 178 189 O
pancreatitis 35 47 190 202 B-chronic_disease
as 48 50 203 205 O
determined 51 61 206 216 O
by 62 64 217 219 O
the 65 68 220 223 O
investigator 69 81 224 236 O

Evidence 0 8 237 245 O
of 9 11 246 248 O
significant 12 23 249 260 O
ascites 24 31 261 268 B-chronic_disease
as 32 34 269 271 O
determined 35 45 272 282 O
by 46 48 283 285 O
the 49 52 286 289 O
investigator 53 65 290 302 O

Female 0 6 303 309 B-gender
patients 7 15 310 318 I-gender
of 16 18 319 321 O
childbearing 19 31 322 334 O
age 32 35 335 338 B-age
must 36 40 339 343 O
have 41 45 344 348 O
negative 46 54 349 357 B-clinical_variable
serum 55 60 358 363 I-clinical_variable
or 61 63 364 366 I-clinical_variable
urine 64 69 367 372 I-clinical_variable
pregnancy 70 79 373 382 I-clinical_variable
test 80 84 383 387 O
within 85 91 388 394 O
1 92 93 395 396 B-upper_bound
week 94 98 397 401 I-upper_bound
of 99 101 402 404 O
beginning 102 111 405 414 O
therapy 112 119 415 422 B-treatment

Hemoglobin 0 10 423 433 B-clinical_variable
> 11 12 434 435 O
9 13 14 436 437 B-lower_bound
g 15 16 438 439 I-lower_bound
/ 16 17 439 440 I-lower_bound
dL 17 19 440 442 I-lower_bound

Known 0 5 443 448 O
to 6 8 449 451 O
be 9 11 452 454 O
HIV+ 12 16 455 459 B-chronic_disease

Other 0 5 460 465 O
current 6 13 466 473 O
malignancy 14 24 474 484 B-cancer
( 25 26 485 486 O
except 26 32 486 492 O
squamous 33 41 493 501 B-cancer
or 42 44 502 504 O
basal 45 50 505 510 B-cancer
cell 51 55 511 515 I-cancer
skin 56 60 516 520 I-cancer
cancers 61 68 521 528 I-cancer
) 68 69 528 529 O

Pathological 0 12 530 542 O
diagnosis 13 22 543 552 O
of 23 25 553 555 O
pancreatic 26 36 556 566 B-cancer
adenocarcinoma 37 51 567 581 I-cancer
adequately 52 62 582 592 O
treated 63 70 593 600 O
with 71 75 601 605 O
induction 76 85 606 615 B-treatment
chemotherapy 86 98 616 628 I-treatment
for 99 102 629 632 O
at 103 105 633 635 O
least 106 111 636 641 O
2 112 113 642 643 B-lower_bound
months 114 120 644 650 I-lower_bound

Patients 0 8 651 659 O
must 9 13 660 664 O
be 14 16 665 667 O
deemed 17 23 668 674 O
to 24 26 675 677 O
be 27 29 678 680 O
in 30 32 681 683 O
adequate 33 41 684 692 O
health 42 48 693 699 O
to 49 51 700 702 O
undergo 52 59 703 710 O
major 60 65 711 716 B-treatment
surgery 66 73 717 724 I-treatment
( 74 75 725 726 O
pancreaticoduodenectomy 75 98 726 749 B-treatment
) 98 99 749 750 O

Patients 0 8 751 759 O
on 9 11 760 762 O
systemic 12 20 763 771 B-treatment
corticosteroids 21 36 772 787 I-treatment

Patients 0 8 788 796 O
with 9 13 797 801 O
biliary 14 21 802 809 O
obstruction 22 33 810 821 O
must 34 38 822 826 O
be 39 41 827 829 O
stented 42 49 830 837 O
prior 50 55 838 843 O
to 56 58 844 846 O
initiating 59 69 847 857 O
treatment 70 79 858 867 B-treatment

Performance 0 11 868 879 B-clinical_variable
status 12 18 880 886 I-clinical_variable
ECOG 19 23 887 891 I-clinical_variable
0 24 25 892 893 B-lower_bound
- 25 26 893 894 O
1 26 27 894 895 B-upper_bound

Platelets>100,000 0 17 896 913 B-clinical_variable
/ 17 18 913 914 I-lower_bound
mm3 18 21 914 917 I-lower_bound

Pregnant 0 8 918 926 B-pregnancy

Primary 0 7 927 934 O
hepatic 8 15 935 942 O
dysfunction 16 27 943 954 O
including 28 37 955 964 O
known 38 43 965 970 O
cirrhosis 44 53 971 980 B-chronic_disease
or 54 56 981 983 O
active 57 63 984 990 B-chronic_disease
hepatitis 64 73 991 1000 I-chronic_disease

Resection 0 9 1001 1010 B-treatment
may 10 13 1011 1014 O
include 14 21 1015 1022 O
major 22 27 1023 1028 B-treatment
vascular 28 36 1029 1037 I-treatment
resection 37 46 1038 1047 I-treatment
with 47 51 1048 1052 O
reconstruction 52 66 1053 1067 O
as 67 69 1068 1070 O
needed 70 76 1071 1077 O

SGOT 0 4 1078 1082 B-clinical_variable
( 5 6 1083 1084 I-clinical_variable
AST)<3x 6 13 1084 1091 I-clinical_variable
upper 14 19 1092 1097 I-upper_bound
limit 20 25 1098 1103 I-upper_bound
of 26 28 1104 1106 I-upper_bound
normal 29 35 1107 1113 I-upper_bound

Total 0 5 1114 1119 B-clinical_variable
bilirubin 6 15 1120 1129 I-clinical_variable
â‰¤2mg 16 20 1130 1134 O
/ 20 21 1134 1135 I-upper_bound
dl 21 23 1135 1137 I-upper_bound

Tumor 0 5 1138 1143 B-cancer
accessible 6 16 1144 1154 O
for 17 20 1155 1158 O
injection 21 30 1159 1168 O
that 31 35 1169 1173 O
is 36 38 1174 1176 O
classified 39 49 1177 1187 O
as 50 52 1188 1190 O
borderline 53 63 1191 1201 O
- 63 64 1201 1202 O
resectable 64 74 1202 1212 O
or 75 77 1213 1215 O
locally 78 85 1216 1223 O
advanced 86 94 1224 1232 O
but 95 98 1233 1236 O
considered 99 109 1237 1247 O
potentially 110 121 1248 1259 O
resectable 122 132 1260 1270 O
after 133 138 1271 1276 O
central 139 146 1277 1284 O
review 147 153 1285 1291 O
by 154 156 1292 1294 O
surgical 157 165 1295 1303 O
investigators 166 179 1304 1317 O
( 180 181 1318 1319 O
based 181 186 1319 1324 O
upon 187 191 1325 1329 O
pre 192 195 1330 1333 O
- 195 196 1333 1334 O
induction 196 205 1334 1343 O
chemotherapy 206 218 1344 1356 B-treatment
imaging 219 226 1357 1364 I-treatment
) 226 227 1364 1365 O

WBC>3000 0 8 1366 1374 B-clinical_variable
/ 8 9 1374 1375 I-lower_bound
mm3 9 12 1375 1378 I-lower_bound

allergic 0 8 1379 1387 O
reactions 9 18 1388 1397 O
to 19 21 1398 1400 O
acyclovir 22 31 1401 1410 B-allergy_name

other 0 5 1411 1416 O
systemic 6 14 1417 1425 B-treatment
immunosuppressive 15 32 1426 1443 I-treatment
drugs 33 38 1444 1449 I-treatment

such 0 4 1450 1454 O
that 5 9 1455 1459 O
they 10 14 1460 1464 O
are 15 18 1465 1468 O
a 19 20 1469 1470 O
candidate 21 30 1471 1480 O
for 31 34 1481 1484 O
localized 35 44 1485 1494 B-treatment
therapy 45 52 1495 1502 I-treatment
with 53 57 1503 1507 O
chemoradiation 58 72 1508 1522 B-treatment
followed 73 81 1523 1531 O
by 82 84 1532 1534 O
surgery 85 92 1535 1542 B-treatment
with 93 97 1543 1547 O
or 98 100 1548 1550 O
without 101 108 1551 1558 O
major 109 114 1559 1564 O
vascular 115 123 1565 1573 B-treatment
resection 124 133 1574 1583 I-treatment

valacyclovir 0 12 1584 1596 B-treatment

